 |
市場調査レポート
商品コード
1458068
骨成長刺激装置の世界市場規模、シェア、成長分析、用途別、エンドユーザー別-産業予測、2024～2031年Global Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application(Spinal Fusion, Maxillofacial & Dental), By End User(Hospitals & ASCs, Specialty Clinics) - Industry Forecast 2024-2031 |
||||||
| 骨成長刺激装置の世界市場規模、シェア、成長分析、用途別、エンドユーザー別-産業予測、2024～2031年 |
|
出版日: 2024年03月25日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
骨成長刺激装置の世界市場規模は2022年に19億3,000万米ドルと評価され、予測期間（2024～2031年）のCAGRは4.9%で、2023年の20億2,000万米ドルから2031年には29億7,000万米ドルに成長する展望です。
補助的な治療法である骨成長刺激は、特に骨治癒の文脈でかなりの人気を博しています。骨刺激装置は、自然治癒しない骨折に対して一般的に採用されています。世界的に骨折やスポーツ関連の怪我の発生率が増加していることが、骨成長刺激装置の需要を煽っています。National Spinal Cord Injury Statistical Center（NSCISC）のデータによると、米国では毎年100万人当たり約54件の脊髄損傷（SCI）が発生しています。世界全体では、年間25万人から50万人が脊髄損傷に苦しんでいると、National Center for Biotechnology Informationは報告しています。整形外科手術は、骨成長刺激技術と関連製品の進歩から大きな恩恵を受けています。市場の可能性を考慮し、骨形態形成タンパク質に関する多くの臨床研究が開始されています。これらの刺激剤は、脊椎固定術、歯科、顎顔面手術、骨折修復など、様々な医療セグメントで広く使用されています。変形性関節症や変性性骨疾患の有病率の増加により、市場はさらに拡大しています。さらに、多血小板血漿と骨形態形成タンパク質の急速な普及と需要は、治癒成果を高めることで市場成長に貢献すると予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
骨成長刺激装置の世界市場：用途別
- 市場概要
- 脊椎固定術
- 顎顔面と歯科
- 癒合不全骨折と癒合骨折
骨成長刺激装置の世界市場：エンドユーザー別
- 市場概要
- 病院とASC
- 専門クリニック
- 在宅医療
骨成長刺激装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Zimmer Biomet Holdings, Inc.（米国）
- Stryker Corporation（米国）
- Medtronic plc（アイルランド）
- Orthofix Medical Inc.（米国）
- DJO Global, Inc.（米国）
- Bioventus LLC（米国）
- DePuy Synthes（a Johnson & Johnson Company）（米国）
- Arthrex, Inc.（米国）
- Smith & Nephew plc（英国）
- Elizur Corporation（米国）
- Isto Biologics（米国）
- Ossatec Benelux B.V.（オランダ）
- Terumo Corporation（日本）
- RTI Surgical Holdings, Inc.（米国）
- Bioventus LLC（米国）
- Ember Therapeutics（米国）
- Isto Biologics（米国）
- DePuy Synthes Spine（米国）
- Aetna Inc.（米国）
- Ossatec Benelux B.V.（オランダ）
- BONESUPPORT AB（スウェーデン）
- Regen Lab SA（スイス）
Global bone growth stimulators market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.02 billion in 2023 to USD 2.97 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).
Bone growth stimulation, a supplementary treatment, has gained considerable popularity, especially in the context of bone healing. Bone stimulators are commonly employed for fractures that have not healed naturally. The increasing incidence of bone fractures and sports-related injuries globally is fueling the demand for bone growth stimulators. According to data from the National Spinal Cord Injury Statistical Center (NSCISC), the United States sees approximately 54 cases of spinal cord injury (SCI) per million people each year. Globally, between 250,000 to 500,000 individuals suffer from spinal cord injuries annually, as reported by the National Center for Biotechnology Information. Orthopedic surgeries have greatly benefited from advancements in bone growth stimulation technology and related products. Given the market potential, numerous clinical studies on bone morphogenetic protein have been initiated. These stimulators find widespread use across various medical fields, including spinal fusion, dentistry, maxillofacial procedures, fracture repair, and others. The market is expanding further due to the growing prevalence of osteoarthritis and degenerative bone diseases. Additionally, the rapid adoption and demand for platelet-rich plasma and bone morphogenetic proteins are expected to contribute to market growth by enhancing healing outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the global bone growth stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bone Growth Stimulators Market Segmental Analysis
The global bone growth stimulators market is segmented based on product, application, end user and region. By product, the market is segmented into bone growth stimulation devices, bone morphogenetic proteins, platelet derived growth factor. By end user, the market is segmented into hospitals & ASCS, specialty clinics, home care. By application, the market is segmented into spinal fusion, maxillofacial & dental, nonunion & union bone fractures. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Bone Growth Stimulators Market
The increasing occurrence of orthopedic ailments, including fractures, delayed unions, non-unions, and fractures related to osteoporosis, serves as a major catalyst for the bone growth stimulators market. With the aging population expanding and the frequency of orthopedic conditions on the rise, there is a corresponding escalation in the demand for bone growth stimulators.
Restraints in the Global Bone Growth Stimulators Market
Although bone growth stimulators are generally deemed safe, there are potential side effects and risks linked to their utilization. These may encompass skin irritation, allergic reactions, and discomfort experienced during treatment. Worries regarding potential adverse effects could dissuade certain patients and healthcare practitioners from employing bone growth stimulators.
Market Trends of the Global Bone Growth Stimulators Market
Currently, the bone growth stimulators industry is experiencing notable shifts driven by several significant developments. One prominent trend is the growing demand for treatments that are more patient-friendly and less invasive. Bone growth stimulators are increasingly preferred by healthcare providers and patients alike for their capacity to offer a less invasive option compared to traditional surgical methods, thus promoting bone healing. This trend is particularly evident in the treatment of orthopedic conditions such as spinal fusion, fractures, and others.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Bone Growth Stimulators Market by Application
- Market Overview
- Spinal Fusion
- Maxillofacial & Dental
- Nonunion & Union Bone Fractures
Global Bone Growth Stimulators Market by End User
- Market Overview
- Hospitals & ASCs
- Specialty Clinics
- Home Care
Global Bone Growth Stimulators Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthofix Medical Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DJO Global, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes (a Johnson & Johnson Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arthrex, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elizur Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioventus LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ember Therapeutics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Isto Biologics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes Spine (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aetna Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ossatec Benelux B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BONESUPPORT AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Regen Lab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
